EYE201/MK-8748 Trial Initiated for Neovascular AMD Treatment Comparison
A clinical trial is underway to evaluate the efficacy of tiespectus (MK-8748) compared to aflibercept in treating neovascular age-related macular degeneration.
Asset / Drug
Drug and asset intelligence for EYE201 with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.